Zhejiang Tailin Bioengineering Co

Zhejiang Tailin Bioengineering Co Current Liabilities

The Current Liabilities of Zhejiang Tailin Bioengineering Co (300813.SZ) as of Oct 29, 2026 is 86.41 M CNY. In the previous year, Current Liabilities was 164.95 M CNY — a change of -47.61% (lower).

Current Liabilities

86.41 MCNY

YoY

-47.61%

Last updated:

Current Liabilities of Zhejiang Tailin Bioengineering Co is 2025 86.41 M CNY. Current Liabilities of Zhejiang Tailin Bioengineering Co was 2024 164.95 M CNY. It decreases by -47.61% lower compared to the previous year.

The Zhejiang Tailin Bioengineering Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
43.48 M CNY
Jan 1, 2019
29.25 M CNY
Jan 1, 2020
70.26 M CNY
Jan 1, 2021
56.71 M CNY
Jan 1, 2022
86.84 M CNY
Jan 1, 2023
239.71 M CNY
Jan 1, 2024
164.95 M CNY
Jan 1, 2025
86.41 M CNY
The Zhejiang Tailin Bioengineering Co Current Liabilities history
YEARCurrent LiabilitiesYoY
86.41 MCNY-47.61%
164.95 MCNY-31.19%
239.71 MCNY+176.03%
86.84 MCNY+53.14%
56.71 MCNY-19.29%
70.26 MCNY+140.17%
29.25 MCNY-32.72%
43.48 MCNY-7.68%
47.10 MCNY+107.70%
22.68 MCNY-22.20%
29.15 MCNY+63.57%
17.82 MCNY+32.21%
13.48 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zhejiang Tailin Bioengineering Co Stock analysis

What does Zhejiang Tailin Bioengineering Co do? Zhejiang Tailin Bioengineering Co., Ltd. generates revenue through the research, development, manufacturing, and sales of pharmaceutical equipment, including microbial detection and control technology system products and organic substance analysis instruments. The company's main products consist of consumables, instruments, and equipment used in sterile drug production and quality control, targeting pharmaceutical manufacturers and laboratories. These products serve applications in medical and health, food safety, disease prevention, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection sectors. The firm distributes its products domestically and internationally, with a focus on the Chinese market and overseas markets. The company's revenue streams are derived from the sale of microbial detection and control technology system products, organic substance analysis instruments, and related consumables. Pharmaceutical manufacturers and laboratory facilities are the primary customers purchasing these products for quality assurance and production processes. The application segments include medical and health, food safety, disease prevention, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection, which are served through both domestic and international distribution channels. Zhejiang Tailin Bioengineering's business model centers on selling specialized pharmaceutical equipment to industries requiring sterile drug production and quality control. The firm's products are utilized across multiple sectors such as medical and health, food safety, disease prevention, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection. Sales occur within the domestic market and overseas markets, with a strong emphasis on the Chinese market and international expansion. Zhejiang Tailin Bioengineering Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zhejiang Tailin Bioengineering Co stock

Current Liabilities of Zhejiang Tailin Bioengineering Co is 86.41 M CNY in 2025.

Current Liabilities of Zhejiang Tailin Bioengineering Co changed from 164.95 M CNY to 86.41 M CNY, representing a -47.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Zhejiang Tailin Bioengineering Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Zhejiang Tailin Bioengineering Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Zhejiang Tailin Bioengineering Co

All Key Metrics — Zhejiang Tailin Bioengineering Co